These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 34523949

  • 1. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H, Huang W, Ji X, Huang L, Zou D, Hao M, Deng S, Shen Z, Lu X, Wang J, Song Z, Zhang X, Xue H, Xia S.
    AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
    [Abstract] [Full Text] [Related]

  • 2. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
    Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi JQ, Yan H.
    Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
    [Abstract] [Full Text] [Related]

  • 3. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
    Takasu M, Kondo S, Akiyama Y, Takahashi Y, Maeda S, Baba Y, Kawase T, Ichinohe T, Awai K.
    PLoS One; 2020 Jul; 15(2):e0229607. PubMed ID: 32106239
    [Abstract] [Full Text] [Related]

  • 4. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C.
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [Abstract] [Full Text] [Related]

  • 5. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
    Latifoltojar A, Hall-Craggs M, Rabin N, Popat R, Bainbridge A, Dikaios N, Sokolska M, Rismani A, D'Sa S, Punwani S, Yong K.
    Br J Haematol; 2017 Jan; 176(2):222-233. PubMed ID: 27766627
    [Abstract] [Full Text] [Related]

  • 6. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
    Wennmann M, Neher P, Stanczyk N, Kahl KC, Kächele J, Weru V, Hielscher T, Grözinger M, Chmelik J, Zhang KS, Bauer F, Nonnenmacher T, Debic M, Sauer S, Rotkopf LT, Jauch A, Schlamp K, Mai EK, Weinhold N, Afat S, Horger M, Goldschmidt H, Schlemmer HP, Weber TF, Delorme S, Kurz FT, Maier-Hein K.
    Invest Radiol; 2023 Apr 01; 58(4):273-282. PubMed ID: 36256790
    [Abstract] [Full Text] [Related]

  • 7. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: A large single-center cohort study.
    Zhang Y, Xiong X, Fu Z, Dai H, Yao F, Liu D, Deng S, Hu C.
    Eur J Radiol; 2019 Nov 01; 120():108695. PubMed ID: 31589995
    [Abstract] [Full Text] [Related]

  • 8. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
    Berardo S, Sukhovei L, Andorno S, Carriero A, Stecco A.
    Radiol Med; 2021 Mar 01; 126(3):445-452. PubMed ID: 32812173
    [Abstract] [Full Text] [Related]

  • 9. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
    Sun M, Wang L, Wang C, Ma J, Wang W, Lin L, Ren C, Zhang Y, Cheng J.
    J Magn Reson Imaging; 2024 Jun 01; 59(6):2035-2045. PubMed ID: 37675995
    [Abstract] [Full Text] [Related]

  • 10. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
    Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, Chung HW, Yoon DH.
    Cancer Imaging; 2020 Jan 30; 20(1):14. PubMed ID: 32000858
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole-Body MRI.
    Sun M, Cheng J, Ren C, Zhang Y, Li Y, Wang L, Liu Y.
    J Magn Reson Imaging; 2022 Apr 30; 55(4):1213-1225. PubMed ID: 34558141
    [Abstract] [Full Text] [Related]

  • 12. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C, Hulin C, Latrabe V, Lascaux A, Bordenave L, Hindié E, Marit G.
    Ann Hematol; 2020 Dec 30; 99(12):2869-2880. PubMed ID: 32951093
    [Abstract] [Full Text] [Related]

  • 13. Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging.
    Barwick T, Orton M, Koh DM, Kaiser M, Rockall A, Tunariu N, Blackledge M, Messiou C.
    Br J Radiol; 2021 Apr 01; 94(1120):20200682. PubMed ID: 33733812
    [Abstract] [Full Text] [Related]

  • 14. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
    Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A, D'Sa S, Dikaios N, Sokolska M, Antonelli M, Ourselin S, Yong K, Taylor SA, Halligan S, Punwani S.
    Eur Radiol; 2017 Dec 01; 27(12):5325-5336. PubMed ID: 28656463
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
    ElGendy K, Barwick TD, Auner HW, Chaidos A, Wallitt K, Sergot A, Rockall A.
    Br J Radiol; 2022 Sep 01; 95(1138):20220418. PubMed ID: 35867890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
    Giles SL, deSouza NM, Collins DJ, Morgan VA, West S, Davies FE, Morgan GJ, Messiou C.
    Clin Radiol; 2015 Jun 01; 70(6):614-21. PubMed ID: 25799364
    [Abstract] [Full Text] [Related]

  • 20. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT.
    Paternain A, García-Velloso MJ, Rosales JJ, Ezponda A, Soriano I, Elorz M, Rodríguez-Otero P, Aquerreta JD.
    Eur J Radiol; 2020 Dec 01; 133():109403. PubMed ID: 33202373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.